Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes (Q83756804)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

2

Raffaele De Caterina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

29 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

68-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

3-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

The impact of the Trial Coordinator in the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Hexosamines, insulin resistance, and the complications of diabetes: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The role of protein kinase C activation and the vascular complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Effect of endothelium-specific insulin resistance on endothelial function in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

RAGE, vascular tone and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Oxidative stress and diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

FACTORS AFFECTING THE INSULIN CONTENT OF PANCREAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

10-year follow-up of intensive glucose control in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Diabetic nephropathy: mechanisms of renal disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The role of beta-cell dysfunction in the cardiometabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

A common allele on chromosome 9 associated with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The extended protein kinase C superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Diabetic retinopathy. A synthesis of perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Cardiovascular actions of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Hyperglycemia and glycation in diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The missing link: a single unifying mechanism for diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Biochemical pathways for microvascular complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Disease model: hyperinsulinemia and insulin resistance. Part A-targeted disruption of insulin signaling or glucose transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Effect of insulin in the induction and regression of atherosclerosis in the chick

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Glycemic control and complications in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Critical nodes in signalling pathways: insights into insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The insulin signalling system and the IRS proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Pathogenesis of diabetic microangiopathy. The hemodynamic view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.03.005

10.1016/J.VPH.2011.03.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21453786%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference